PulseAugur
EN
LIVE 08:24:27
ENTITY Zhenbaodao Pharmaceutical

Zhenbaodao Pharmaceutical

PulseAugur coverage of Zhenbaodao Pharmaceutical — every cluster mentioning Zhenbaodao Pharmaceutical across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-05-25 partnership Zhenbaodao Pharmaceutical's subsidiary secured sales agency rights for Zhejiang Teruis's innovative drug TRS005 in China. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_49445 ·

    Zhenbaodao Pharma subsidiary to market innovative cancer drug TRS005 in China

    Zhenbaodao Pharmaceutical's subsidiary has secured the exclusive sales agency rights in China for TRS005, an innovative biological drug developed by Zhejiang Teruis. This drug, designed to treat relapsed or refractory n…